Jun 27, 2025
The Central Drugs Standard Control Organisation (CDSCO) has approved Eli Lilly’s Mounjaro (tirzepatide) KwikPen for adults with type 2 diabetes.
Source: canva
Mounjaro features tirzepatide, a first-in-class drug that mimics two hormones, GLP-1 & GIP, to enhance insulin production
Source: canva
Clinical studies have shown that Mounjaro not only lowers blood glucose but also significantly helps in weight reduction.
Source: canva
Mounjaro comes in an easy-to-use pre-filled injection pen for weekly administration.
Source: canva
Common side effects reported include nausea, vomiting, and diarrhea, especially during the initial dosing.
Source: canva
Early comparisons suggest tirzepatide may outperform existing GLP-1 treatments.
Source: canva
The drug will be priced at Rs 3,500 for a 2.5 mg vial and Rs 4,375 for the 5 mg vial.
Source: canva
Cirrhosis: 7 Early Symptoms to Watch Out For